Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds ...
Volatility & Risk Permex Petroleum has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500. Comparatively, Permex Petroleum’s competitors have a beta of 8.13, meaning ...